Cover Image

Comparison of cardiotoxicity between N-methyl-glucamine and miltefosine in the treatment of American cutaneous leishmaniasis

Saved in:

Bibliographic Details
Main Authors:	Daniel Holanda Barroso (Author), Ciro Martins Gomes (Author), Antônia Marilene da Silva (Author), Raimunda Nonata Ribeiro Sampaio (Author)
Format:	Book
Published:	Sociedade Brasileira de Dermatologia, 2021-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

O uso da associação azitromicina e N-metil glucamina no tratamento da leishmaniose cutânea causada por Leishmania (Leishmania) amazonensis em camundongos C57BL6 The use of azythromycin and N-methyl glucamine for the treatment of cutaneous Leishmaniasis caused by Leishmania (Leishmania) amazonensis in C57BL6 mice
by: Raimunda Nonata Ribeiro Sampaio, et al.
Published: (2009)

Successful treatment of multifocal cutaneous leishmaniasis with miltefosine
by: Bhushan Madke, et al.
Published: (2011)

Tratamento da Leishmaniose Tegumentar Americana Treatment of american cutaneous leishmaniasis
by: Edson Borges de Lima, et al.
Published: (2007)

Use of miltefosine in the treatment of cutaneous leishmaniasis in French Guiana
by: Charlene Oliveira, et al.
Published: (2024)

Dynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosine.
by: Thomas P C Dorlo, et al.
Published: (2011)

Recurrent cutaneous leishmaniasis Leishmaniose recidiva cútis
by: Ciro Martins Gomes, et al.
Published: (2013)

Miltefosine for the treatment of cutaneous leishmaniasis-A pilot study from Ethiopia.
by: Saskia van Henten, et al.
Published: (2021)

Monitoring Cutaneous Leishmaniasis Lesions in Mice Undergoing Topical Miltefosine Treatment
by: Laura Fernanda Neira, et al.
Published: (2023)

Complementary exams in the diagnosis of american tegumentary leishmaniasis
by: Ciro Martins Gomes, et al.
Published: (2014)

Lutzomyia whitmani is the main vector of American Cutaneous Leishmaniasis in the Brazilian Federal District and the most prevalent species in residential areas of the Administrative Region of Sobradinho
by: Mariana Boff Barreto, et al.
Published: (2014)

Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients
by: Ayelet Ollech, et al.
Published: (2020)

Successful treatment of diffuse cutaneous leishmaniasis caused by Leishmania amazonensis,
by: Raimunda Nonata Ribeiro Sampaio, et al.
Published: (2021)

The effect of oral miltefosine in treatment of antimoniate resistant anthroponotic cutaneous leishmaniasis: An uncontrolled clinical trial.
by: Masoumeh Tayyebi, et al.
Published: (2021)

Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis.
by: Brandon A Berger, et al.
Published: (2017)

Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.
by: Paulo R Machado, et al.
Published: (2010)

Glutamine supplementation improves the efficacy of miltefosine treatment for visceral leishmaniasis.
by: Carolina Ferreira, et al.
Published: (2020)

Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis
by: Sankha Koley, et al.
Published: (2013)

In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis.
by: Adriano C Coelho, et al.
Published: (2014)

Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study.
by: Maria Del Mar Castro, et al.
Published: (2017)

American cutaneous leishmaniasis in Brazil
by: Viroj Wiwanitkit
Published: (2015)

Urban American cutaneous leishmaniasis
by: Francisca Regina Oliveira Carneiro, et al.
Published: (2018)

Complex cutaneous infection by Leishmania mexicana treated with miltefosine
by: Rachel L. Sadowsky, BA, et al.
Published: (2022)

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.
by: Monique Wasunna, et al.
Published: (2016)

In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis: Follow-Up.
by: Adriano C Coelho, et al.
Published: (2016)

Estudo comparativo de técnicas de demonstração de amastigotas e isolamento de promastigotas no diagnóstico da leishmaniose tegumentar americana Comparative study of parasitological techniques for demonstration of amastigotes and primary isolation of promastigotes in American Cutaneous leishmaniasis
by: Raimunda Nonata Ribeiro Sampaio, et al.
Published: (2002)

Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis.
by: Andrew A Voak, et al.
Published: (2021)

Periungual leishmaniasis Leishmaniose periungueal
by: Ciro Martins Gomes, et al.
Published: (2012)

Direct comparison of the efficacy and safety of oral treatments with oleylphosphocholine (OlPC) and miltefosine in a mouse model of L. major cutaneous leishmaniasis.
by: Anny Fortin, et al.
Published: (2014)

Leprosy and American cutaneous leishmaniasis coinfection
by: Larissa Mondadori Mercadante, et al.
Published: (2018)

Occupationally Acquired American Cutaneous Leishmaniasis
by: Maria Edileuza Felinto de Brito, et al.
Published: (2012)

Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.
by: Vasundhra Bhandari, et al.
Published: (2012)

Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.
by: Suzette Kämink, et al.
Published: (2021)

Estudo clínico, epidemiológico e terapêutico de 402 pacientes com leishmaniose tegumentar americana atendidos no Hospital Universitário de Brasília, DF, Brasil Clinical, epidemiological and therapeuthic study of 402 patients with american cutaneous leishmaniasis attended at University Hospital of Brasilia, DF, Brazil
by: Roberto Querido Name, et al.
Published: (2005)

Spatial analysis of American cutaneous leishmaniasis in the state of Amazonas
by: Mirely Ferreira dos Santos, et al.
Published: (2024)

Predicting relapse after treatment for American cutaneous leishmaniasis
by: Sierra Romero Gustavo Adolfo
Published: (2001)

Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India.
by: V Ramesh, et al.
Published: (2015)

A phase II multicenter randomized study to evaluate the safety and efficacy of combining thermotherapy and a short course of miltefosine for the treatment of uncomplicated cutaneous leishmaniasis in the New World.
by: Liliana López, et al.
Published: (2022)

Correction: Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India.
by: V Ramesh, et al.
Published: (2015)

Clinical and epidemiological aspects of American cutaneous leishmaniasis with genital involvement,
by: Marcelo Rosandiski Lyra, et al.
Published: (2020)

American Cutaneous Leishmaniasis: Imported cases in Berlin 2000-2023.
by: Andreas K Lindner, et al.
Published: (2024)